Status:
COMPLETED
Magnetic Resonance Imaging and Spectroscopy Biomarkers of Neonatal Hypoxic Ischemic Encephalopathy
Lead Sponsor:
University Children's Hospital, Zurich
Conditions:
Hypoxic Ischemic Encephalopathy
Eligibility:
All Genders
Up to 2 years
Brief Summary
Neonatal hypoxic ischemic encephalopathy (HIE) is a serious neurological condition characterised by acute or subacute brain injury arising from perinatal hypoxia. HIE is thought to affect approximatel...
Eligibility Criteria
Inclusion
- Newborn infants (born at \>36 weeks) with suspected perinatal asphyxia. Written informed consent from both parents.
Exclusion
- Prematurity (born at \< 36 weeks). Lack of written informed consent from both parents.
Key Trial Info
Start Date :
September 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 9 2019
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT01481207
Start Date
September 1 2011
End Date
July 9 2019
Last Update
September 25 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Children's Hospital Zurich, MRI Center
Zurich, Switzerland, 8032